Prenyl modification of proteins by farnesyl and geranylgeranyl isopren
oids occurs in a variety of eukaryotic cells. Culturing of Trypanosoma
brucei in the presence of [H-3]mevalonolactone (which is hydrolyzed i
n cells to give mevalonic acid, the precursor of protein prenyl groups
) and an inhibitor of mevalonic acid biosynthesis leads to the radiola
beling of a specific set of proteins when analyzed by gel electrophore
sis. T. brucei proteins were also labeled when cells were cultured in
the presence of [H-3]farnesol or [H-3]geranylgeraniol, and each prenol
labels a distinct set of proteins. Unlike mammalian cells, only a few
T. brucei proteins of molecular weights similar to those of the mamma
lian Pas superfamily of GTPase (20-30 kDa) were labeled with [H-3]farn
esol or [H-3]geranylgeraniol. When the 0-55% ammonium sulfate fraction
of T. brucei cytosol was fractionated on anion exchange chromatograph
y, protein farnesyltransferase (PFT) and protein geranylgeranyltransfe
rase-I (PGGT-I) activities were detected and elute as two distinct pea
ks. Partially purified T. brucei PFT and PGGT-I display partly differe
nt specificities toward prenyl acceptor substrates from those of mamma
lian protein prenyltransferases. As shown previously, rat PFT utilizes
proteins ending in CVLS and CVIM as efficient prenyl accepters and ra
t PGGT-I utilizes proteins ending in CVLL and CVIM in vitro. On the co
ntrary, T. brucei PFT farnesylates a protein ending in CVIM but not CV
LS or CVLL, and T. brucei PGGT-I preferentially geranylgeranylates a p
rotein ending in CVLL. (C) 1997 Elsevier Science B.V.